We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.



Your filtered view of the latest news and analysis

  • HCM ups clinical trial spend

    27 February 2015

    Hutchison China MediTech upped its spending on clinical trials last year - at the expense of profitability.
  • Circassia gears up for US launch Tip Update

    27 February 2015

    Circassia is gearing up to launch its cat allergy treatment in the lucrative US allergy market.
  • Russian trouble for Genus

    24 February 2015

    Genetics specialist Genus insists its full-year performance won't be hurt by turbulence in Russia
  • Dechra beats the currency crunch

    24 February 2015

    Dechra Pharmaceuticals enjoyed a strong six months despite strong currency headwinds and curbs on antibiotic prescriptions in Europe.
  • Sinclair IS weighs its options

    17 February 2015

    Sinclair IS Pharma (SPH) is reviewing a number of options to transform the group's future
  • Shire storms ahead Tip Update

    13 February 2015

    Shire's 2014 was marked by a failed takeover bid, but its prospects as a standalone company are solid.
  • Indivior carves its own path

    11 February 2015

    Newly-independent pharma group Indivior (INDV) has released its first set of results since demerging from Reckitt Benckiser (RB.)
  • Vernalis awaits FDA decision

    10 February 2015

    Vernalis has changed its financial year-end as it waits for US regulators to approve a new product
  • Long-term focus for AstraZeneca

    06 February 2015

    Full-year results for pharma giant AstraZeneca don't look good, but the City remains optimistic about the group's long-term future.
  • GSK hopes for a better 2015 Tip Update

    05 February 2015

    The drugs giant is looking forward to a better year after sluggish sales and a corruption drama hindered progress in 2014
  • Indivior faces generic challenge

    02 February 2015

    Little is known about Reckitt Benckiser's pharma spin-off Indivior, which was only demerged in December
  • Shire back in business

    02 February 2015

    Shire will want to put AbbVie's failed takeover bid well and truly behind it when it reports results next week.

Register today and get...

Register today and get...
Please note terms & conditions apply